Cara Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/13/2024 | 2.25 M | $692,664 | -0.06% | 4.10% |
| CHESCAPMANAGER LLC | 11/14/2024 | 1.70 M | $524,250 | 0.00% | 3.10% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.56 M | $479,325 | 0.00% | 2.84% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 11/15/2024 | 1.11 M | $342,817 | -42.50% | 2.03% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.11 M | $341,551 | 4.05% | 2.02% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 866,300 | $266,820 | 0.55% | 1.58% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 742,477 | $228,682 | 100.00% | 1.35% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 587,909 | $181,076 | 0.20% | 1.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 452,249 | $139,329 | -4.32% | 0.82% |
| STIFEL FINANCIAL CORP | 11/14/2024 | 332,995 | $102,563 | -24.86% | 0.61% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 327,233 | $100,788 | -31.50% | 0.60% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 240,912 | $74,201 | -5.22% | 0.44% |
| FMR LLC | 11/13/2024 | 210,312 | $64,776 | 18.47% | 0.38% |
| STATE STREET CORP | 11/14/2024 | 180,400 | $55,563 | -0.22% | 0.33% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 159,469 | $49,116 | 0.00% | 0.29% |
| LPL FINANCIAL LLC | 11/08/2024 | 149,045 | $45,906 | -1.42% | 0.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 127,553 | $39,286 | -31.37% | 0.23% |
| XTX TOPCO LTD | 11/14/2024 | 94,709 | $29,170 | 100.00% | 0.17% |
| TUDOR INVESTMENT CORP ET AL | 11/14/2024 | 93,116 | $28,680 | 0.00% | 0.17% |
| PENSERRA CAPITAL MANAGEMENT LLC | 11/12/2024 | 63,506 | $19,000 | -6.72% | 0.12% |
| B. RILEY WEALTH ADVISORS, INC. | 12/13/2024 | 58,458 | $16,663 | -5.11% | 0.11% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 58,094 | $18,000 | -23.55% | 0.11% |
| JANE STREET GROUP, LLC | 11/15/2024 | 53,506 | $16,480 | -85.79% | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 45,510 | $13,000 | -82.97% | 0.08% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 44,633 | $13,747 | -32.99% | 0.08% |
| FERGUSON WELLMAN CAPITAL MANAGEMENT, INC | 11/06/2024 | 34,780 | $10,712 | 100.00% | 0.06% |
| RATHBONES GROUP PLC | 11/13/2024 | 20,164 | $6,211 | 0.00% | 0.04% |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 11/13/2024 | 19,864 | $6,118 | 0.00% | 0.04% |
| MORGAN STANLEY | 11/14/2024 | 16,160 | $4,978 | -76.68% | 0.03% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 13,998 | $4,311 | -57.59% | 0.03% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 13,653 | $4,205 | -4.88% | 0.02% |
| CERTUITY, LLC | 11/12/2024 | 12,682 | $3,906 | 100.00% | 0.02% |
| PINNACLE ASSOCIATES LTD | 10/25/2024 | 11,727 | $8,713 | -79.55% | 0.02% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 11,329 | $2,902 | 0.00% | 0.02% |
| JAG CAPITAL MANAGEMENT, LLC | 11/04/2024 | 11,235 | $3,460 | 0.00% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 9,458 | $2,930 | -12.17% | 0.02% |
| SRS CAPITAL ADVISORS, INC. | 11/06/2024 | 7,571 | $2,332 | 0.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 5,297 | $1,631 | -76.49% | 0.01% |
| JPMORGAN CHASE & CO | 11/08/2024 | 5,253 | $1,618 | -92.98% | 0.01% |
| CYPRESS CAPITAL MANAGEMENT LLC (WY) | 11/05/2024 | 5,000 | $1,540 | 0.00% | 0.01% |
| LRI INVESTMENTS, LLC | 11/15/2024 | 3,000 | $983 | 50.00% | 0.01% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 2,020 | $622 | 100.00% | 0.00% |
| UBS GROUP AG | 11/14/2024 | 1,872 | $577 | -97.44% | 0.00% |
| NEWEDGE ADVISORS, LLC | 11/14/2024 | 1,165 | $359 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 1,086 | $334 | -11.42% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 849 | $261 | -97.56% | 0.00% |
| WR WEALTH PLANNERS, LLC | 10/17/2024 | 746 | $230 | 100.00% | 0.00% |
| MCILRATH & ECK, LLC | 11/19/2024 | 736 | $227 | 0.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 10/23/2024 | 719 | $222 | 0.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 11/04/2024 | 525 | $162 | 0.00% | 0.00% |
Cara Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 128 institutional investors and hedge funds held shares of Cara Therapeutics, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 2.25 M
Chescapmanager LLC: 1.7 M
FARALLON CAPITAL MANAGEMENT LLC: 1.56 M
DISCIPLINED GROWTH INVESTORS INC /MN: 1.11 M
RENAISSANCE TECHNOLOGIES LLC: 1.11 M
TWO SIGMA ADVISERS, LP: 866,300
24.66% of Cara Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 17.52 M shares in the last 24 months. This purchase volume represents approximately $7.36 M in transactions.